Procymate
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Clinical data | |
---|---|
Routes of administration |
oral |
ATC code | none |
Identifiers | |
|
|
CAS Number | 13931-64-1 Y |
PubChem (CID) | 3050432 |
ChemSpider | 2312494 N |
UNII | 308EUN932K Y |
ChEMBL | CHEMBL2104652 N |
Chemical and physical data | |
Formula | C10H19O2 |
Molar mass | 185.263 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
NY (what is this?) (verify) |
Procymate (Equipax) is a carbamate derivative which is a sedative and anxiolytic drug. It was previously manufactured and marketed in Belgium. The usual dose for adults is 800 to 1200 mg per day.[1] Procymate shares a similar structure and mechanism of action with the related drugs hexapropymate and phenprobamate.
References[edit]
- ^ "Procymate," Bank of Automated Data on Drugs. VIDAL Drug Database. <http://www.biam2.org/www/Sub394.html>
Alcohols | |
---|---|
Barbiturates |
|
Benzodiazepines |
|
Carbamates | |
Flavonoids |
|
Imidazoles | |
Kava constituents | |
Monoureides | |
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols | |
Piperidinediones | |
Pyrazolopyridines | |
Quinazolinones | |
Volatiles/gases |
|
Others/unsorted |
|
See also: GABAergics
|
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://en.wikipedia.org/w/index.php?title=Procymate&oldid=713235690"